Impact of atrial fibrillation ablation on cardiac sympathetic nurve system - Investigation using iodine-123 metaiodobenzylguanidine imaging

Impact of atrial fibrillation ablation on cardiac sympathetic nurve system - Investigation using iodine-123 metaiodobenzylguanidine imaging - Impact of atrial fibrillation ablation on cardiac sympathetic nurve system - Investigation using iodine-123 metaiodobenzylguanidine imaging

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000009293

Enrollment

Registered

2012-11-08

Start date

2012-11-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing initial ablation for atrial fibrillation

Exclusion criteria

Exclusion criteria: pregnancy

Design outcomes

Primary

Measure	Time frame
Changes in H/M ratio and WR on Cardiac iodine-123 metaiodobenzylguanidine imaging before and after ablation	—

Countries

Japan

Outcome results